Chapter 37: Principles of Antimicrobial Chemotherapy

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

We are doing something a little different today.

Usually we are swimming through a sea of articles, news clips, and opinion pieces.

A lot of different sources.

Exactly.

But today, today we are going back to, well, the absolute bedrock.

We're taking a dense stack of pages, specifically chapter 37 from Brenner and Stevens' Pharmacology, and we are going to dismantle it, examine it, and put it back together so that it actually makes sense.

It is a back -to -basics approach, and I think it's incredibly necessary.

We are looking at the principles of antimicrobial chemotherapy.

Now, I have to stop you right there because I know what everyone is thinking.

I know what I thought when I saw the title of this chapter, chemotherapy.

You hear that word, and your brain immediately goes to a very specific, very scary place.

You think of cancer, hair loss, oncology wards, and IV drips.

Which is a completely natural association.

In modern conversation, that is almost exclusively how we use the word.

But if we are going to be rigorous, and if we are going to follow the text, we have to widen the aperture.

The definition of chemotherapy in this context is actually much It is defined as the use of any drug to eradicate a pathogenic organism or a neoplastic cell.

So let me get this straight.

If I have strep throat and I take a course of penicillin, technically, in the eyes of a pharmacologist, I am undergoing chemotherapy.

Technically, yes.

It covers infectious diseases and cancer.

And the reason they are grouped together in the textbook is that the core philosophy connecting them is identical.

Which is?

Whether you are trying to kill a tumor cell or a staphylococcus bacteria, you are operating on the principle of selective toxicity.

Okay, let's unpack that.

Selective toxicity.

It sounds like a bit of a marketing buzzword, doesn't it?

We kill the bad stuff, save the good stuff.

It does.

But chemically, how do you actually pull that off?

I mean, a cell is a cell, right?

We have DNA, bacteria have DNA, we have proteins, they have proteins.

We are all just, you know, bags of water driven by chemistry.

That is the fundamental problem of pharmacology.

If you look at it from a high altitude, a human cell and a bacterial cell are remarkably simpler.

Right.

So if I have a sore throat and I decide to gargle with bleach, which, legal disclaimer, please nobody do this.

Please do not.

I will definitely kill the bacteria.

You absolutely will.

You will obliterate them.

But I'll also strip the lining of my esophagus and probably end up in the emergency room.

Exactly.

That is general toxicity.

Bleach is a non -selective killer.

It destroys protein and lipid membranes indiscriminately.

Selective toxicity requires us to be biological snipers.

Snipers, okay.

We have to find a target, a specific protein, a structural wall, an enzyme that the invader must have to survive, but that the host, the human, completely lacks.

We're looking for biological differences.

Major ones.

You're looking for a qualitative or quantitative difference in the cellular machinery.

Okay.

Give me the best example of this.

What is the biggest difference between me and a bacterium?

The hull of the ship.

The cell wall.

Exactly.

Think about human cells.

We are squishy.

We have cell membranes, flexible lipid bilayers.

We are essentially complex water balloons.

Right.

But bacteria, they are under immense internal pressure.

How much pressure are we talking about?

Massive.

If a bacterium didn't have a rigid, hard shell, the cell wall, it would literally explode from its own internal osmotic pressure.

It would pop like a champagne cork.

So if we can find a drug that prevents them from building that wall.

We don't even have to kill them directly.

We just stop the maintenance of the wall and they blow themselves up.

And the beauty is, since humans don't have cell walls, the drug flows right past our cells without scratching the paint.

That's incredible.

That is the perfect example of selective toxicity.

That makes the state so much clearer.

It's not just about poisoning the bug.

It's about exploiting a structural weakness that we don't have.

Precisely.

Now the text breaks this down into three huge categories.

Antimicrobial, antiparasitic, and antineoplastic.

But for today's deep dive, our mission is to master the first one.

Got it.

We are focusing strictly on antimicrobial drugs.

That means antibacterial, antifungal, and antiviral agents.

We are decoding the logic of how we treat infections.

To do that properly, I feel like we have to look backward before we look forward.

The text has this fascinating section on the origins of these drugs.

It wasn't always white coats and sterile labs.

No, it certainly wasn't.

It started much more organically.

I mean, the text mentions moldy bean curds.

It does.

It's a fantastic detail.

The text notes that the earliest antibiotic use was likely by ancient Chinese and Egyptian cultures who applied moldy bean curd to skin infections.

Which is wild to think about.

They didn't know what bacteria were.

They didn't have microscopes.

No idea.

But they knew that this specific funky food product helped heal a wound.

And that distinguishes a key difference the chapter highlights early on.

The difference between an antibiotic and a synthetic compound.

Break that down for us because I think most people use those words interchangeably.

Most people do, but there is a nuance.

An antibiotic is, by definition, a substance produced by a microbe that inhibits another microbe.

It's natural warfare.

So the mold on the bean curd is fighting the bacteria on the skin.

Exactly.

So antibiotics are basically nature's biological weapons.

The mold isn't making penicillin to help us.

It's making it to protect its own lunch from the bacteria.

That is a very accurate way to put it.

We just hijacked their weaponry.

The scientific roots of this really took hold with Louis Pasteur and Paul Newman.

Okay.

They observed what they called anti -biosis.

One bacterium antagonizing another.

They predicted that one day we'd use substances derived from microbes to treat disease.

And that leads us to the big one.

The story everyone knows, but it's still cool.

Alexander Fleming.

The accidental discovery is the stuff of legend.

Fleming was working with staphylococcal cultures bacteria and a mold contaminant, a penicillium fungus, got onto the plate.

Which usually would just mean you ruined your experiment.

Great.

My plate is moldy.

Into the trash.

Exactly.

But Fleming was observant.

He noticed the bacteria wouldn't grow near the mold.

There was a clear zone around the fungus where the bacteria couldn't survive.

He postulated the fungus was producing a substance penicillin that inhibited the bacteria.

And just like that, the antibiotic era begins.

But the text also talks about the synthetics.

These aren't microbe on microbe warfare.

These are man -made chemicals.

Right.

And here we have to talk about Paul Ehrlich.

The text calls him the father of chemotherapy.

This is the guy who was looking for the magic bullet, right?

That was his term.

He was obsessed with finding those selectively toxic compounds we mentioned earlier.

He actually discovered arsphenamine, also known as selfersan, which was an arsenical compound used to treat syphilis.

Arsenic.

That sounds risky.

It was.

It was incredibly toxic.

But it was slightly more toxic to the syphilis spirit than it was to the patient.

It was a narrow window, but it was better than the alternative at the time.

But here is where it gets really interesting to me.

Ehrlich wasn't just mixing chemicals at random.

He was studying bacterial stains dyes used to color bacteria under a microscope.

Yes.

This is a brilliant leap of logic.

He noticed that certain dyes would stain the bacteria, but wash right off the human tissue on the slide.

Okay, so he's looking at dyed bacteria.

What's the connection to drugs?

He reasoned that if a dye has a selective affinity for a bacterium, meaning it chemically sticks to the bug, but not the human tissue,

could you couple that dye with a toxin?

Oh, wow.

Could the dye act as a delivery system?

So if I can color it, I can kill it?

Essentially.

And that line of thinking led to the discovery of sulfonamides.

They were originally derived from a red bacterial stain called Prontosil.

These were the first effective drugs for systemic bacterial infections.

So we went from bean curd to arsenic to red dye, and finally to the modern pharmacy shelf.

That is quite a journey.

It is.

But once we had these drugs, we had to organize them.

We couldn't just have a bucket of germ killers.

Right.

The text explains that we classify these drugs in a few ways.

By their chemical structure, sure, but more importantly for us, by their site of action.

Right.

The text references figure 37 .1, which is this great diagram of a bacterial cell being attacked from all angles.

I want you to visualize that cell.

Imagine it's a fortress under siege.

To take it down, you have four main strategies.

Okay, let's play general.

Strategy number one.

Attack the walls.

These are the cell wall synthesis inhibitors.

This goes back to our champagne cork analogy.

Drugs like penicillins, cephalosporins, and vancomycin.

How do they work exactly?

Did they smash the wall?

Not exactly.

They stop the bacteria from repairing and building the wall.

Imagine you are building a brick house, and someone comes along and steals all the mortar.

You can stack the bricks, but they won't hold.

Eventually, the internal pressure blows the wall out and the cell bursts.

Brutal.

Okay, strategy number two.

Attack the factories inside.

These are the protein synthesis inhibitors.

These are the ones that go after the ribosomes.

Yes.

The ribosomes are the machinery translating genetic code into proteins.

Proteins are the workers, the enzymes, the structures.

If you jam the gears of the ribosome, the bacteria can't function.

This includes drugs like tetracyclines, immunoglycosides, and macrolides.

But wait, human cells have ribosomes too.

Why don't these drugs stop our protein synthesis?

Great question.

That goes back to selective toxicity.

Bacterial ribosomes are slightly different in size and shape compared to human ribosomes.

We call them 70S ribosomes, whereas humans have 80S.

70S versus 80S.

The drugs fit the bacterial 70S lock, but not the human 80S lock.

It's amazing that such a small difference saves us from toxicity.

Okay, strategy three.

Cut off the supply lines with the command center.

These are the metabolic and nucleic acid inhibitors.

Give us some examples.

You have sulfonamides, which block folate synthesis.

Bacteria need to make their own folate to grow.

Humans just eat it in our diet.

So we get it from our food.

Right.

So if you block that factory, the bacteria starve, but we are fine.

And nucleic acid ones?

Those attack the DNA or RNA directly.

Fluoroquinolones block an enzyme called DNA gyrase.

Imagine trying to read a scroll, but the scroll is tangled into a chaotic knot.

DNA gyrase untangles the DNA so it can be read.

If you block that, the bacteria can't replicate its genetic code.

So the command center goes dark.

And the final strategy.

Cell membrane inhibitors.

Drugs like amphotericin or polymixin.

Now, remember I said the cell wall is the hard shell.

The membrane is the soft skin underneath.

These drugs disrupt that flexible membrane.

Like popping the water balloon inside the box.

Exactly.

They act almost like detergents.

They break up the lipid structure, the contents leak out, and the cell dies.

So we have wall breakers, factory saboteurs, supply line cutters, and balloon poppers.

That covers the how, but we also need to talk about the result.

When you use these drugs, what actually happens to the bacteria?

This brings us to the distinction between bactericidal and bacteriostatic.

I feel like I see these terms a lot on labels or in articles, but I never quite grasped the clinical difference.

Is one just stronger than the other?

Not necessarily stronger, but they have a different tactical goal.

Bactericidal means the grug kills the organism,

dead, irreversible.

Bacteriostatic means it inhibits growth, but doesn't necessarily kill them outright.

It just pushes the pause button on their reproduction.

The text has a graph for this, figure 37 .2.

It visualizes this perfectly.

Yes.

Picture a graph showing the number of bacteria over time.

You have a control line that just shoots straight up.

That's logarithmic growth.

The bacteria are partying, dividing, doubling every 20 minutes.

Then you add a bacteriostatic drug like tetracycline.

And the line goes flat.

It doesn't drop to zero, but it stops going up.

The number of bacteria remains constant.

Okay, but if they aren't dead, how do you get cured?

If I take tetracycline, I don't want the bacteria just hanging out in limbo forever.

That is the key question.

With the bacteriostatic drug, you are relying on the patient's own immune system to come in and mop up the mess.

The drug holds the bacteria down.

It pins their arms to their sides so the white blood cells can come in and finish the job.

Whereas with a bactericidal drug.

Like penicillin, the line on the graph drops rapidly.

The drug itself is doing the killing.

So why does this matter?

Why would I ever choose the pause button drug if I can have the killer?

Why not just nuke them every time?

Well, sometimes the pause button drugs are less toxic to the patient or they have better coverage for a specific bug.

But what if your patient doesn't have an immune system?

Right.

If the cleanup crew is on strike, pinning the bacteria down doesn't help.

Exactly.

If your patient has a compromised immune system, say they have HIV AIDS or they're on cancer chemotherapy or high dose steroids,

you cannot rely on a bacteriostatic drug.

It won't work.

Their immune system can't finish the job.

In those cases, you generally need a bactericidal drug.

You need the drug to do the heavy lifting because the body can't.

That makes total sense.

Now, speaking of choosing drugs, we also have to talk about spectrum.

Right.

We have narrow spectrum, broad spectrum, and extended spectrum.

Narrow spectrum sounds like it might be bad like limited.

Sorry, this phone only calls one area code, but the text says it's often preferred.

It is.

Think of narrow spectrum as a sniper rifle.

It hits a specific group like just gram -positive bacteria.

It's preferred because it kills the bad guy, but it leaves the innocent civilians, your normal gut flora alone.

Because our gut is full of good bacteria that help us digest food and make vitamins.

Exactly.

And if you wipe them out, you leave room for bad things to grow.

Which brings us to broad spectrum, the shotgun approach.

Correct.

Broad spectrum kills a wide range.

Gram -positives, gram -negatives, everybody.

You use this when you don't know what the bug is yet.

So like in an emergency.

Exactly.

The patient is sick.

They're septic.

You need to start treatment now.

So you use a broad spectrum drug to cover all the bases.

But the downside is the collateral damage.

Huge collateral damage.

You wipe out the good bacteria, which can lead to super infections like C.

difficile colitis or yeast infections.

Okay.

So we've covered the types of weapons, the mechanisms, and the damage they do.

Cytal versus static.

Now we need to get into the nitty gritty of how we dose them.

I want to get practical here.

I'm a doctor.

I have these weapons.

How do I fire them?

The text introduces this concept of pharmacodynamics, which seems to be the debate between how much and how long.

This is the crucial distinction.

And it changes how you take your pills.

It explains why some pills are once a day and some are four times a day.

There are three key acronyms here you need to know.

Let's hit the first one.

MIC.

Minimal Inhibitory Concentration.

This is the lowest amount of drug needed to stop bacterial growth.

This is your baseline.

This is the height of the hurdle.

Okay.

If you can't reach the MIC at the site of infection,

you aren't treating the infection.

Simple enough.

You have to be tall enough to ride the ride.

What about CDKR?

Concentration -Dependent Killing Rate.

This is a property of certain drugs like aminoglycosides,

Tobromycin is the example in the text, and fluoroquinolones like ciprofloxacin.

What does it mean practically?

It means the harder you hit them, the faster they fall.

Think of it like a boxing match.

A concentration -dependent drug is a knockout punch.

You want to hit them as hard as possible all at once.

So for these drugs, one massive dose is better than 10 small jabs.

Precisely.

If you raise the concentration from barely enough 1x MIC to 10 times that amount, the bacteria die exponentially faster.

That's why for Tobromycin, we might give one giant dose once a day.

We want that huge peak in the blood.

But contrast that with penicillins.

The text says they generally do not exhibit this property.

Right.

Penicillins are time -dependent.

You can give a massive dose a million times the necessary amount, and it won't kill the bacteria any faster than a moderate dose.

Really?

Why not?

Because penicillins work by sabotaging the wall -building process.

They can only work when the bacteria are actively trying to build and divide.

You can't rush it.

It's like trying to drown someone.

That got dark quickly.

It's a morbid analogy, but it works.

Holding someone's head underwater 10 feet deep isn't any more effective than holding it one foot deep.

You just have to hold it there long enough.

So for penicillin, the height of the wave doesn't matter as much as the duration of the flood.

Exactly.

We need the drug level to stay above that MIC for as many hours as possible.

That's why you have to take penicillin four times a day.

If you miss a dose, the water level drops, the bacteria take a breath, and you lose the progress.

It's amazing how these biological properties dictate the schedule on the prescription bottle.

It's not arbitrary.

It's biology.

It really is.

And there is one more factor,

PAE.

Post -antibiotic effect.

I like to call this the hangover effect.

That is a perfect description.

Imagine you have treated the bacteria, and then the drug is removed.

The concentration drops to zero.

With some drugs, the bacteria start growing back immediately.

And not these ones.

But with drugs that have a PAE, the bacteria stay suppressed for hours after the drug is gone.

They're still recovering from the punch.

Exactly.

They are stunned.

Figure 37 .3b shows this beautifully.

The drug is removed at hour two, but the growth line stays flat until hour six or eight.

And this changes how we give the drug.

Huge impact.

This is another reason we can give M &L glycosides once a day.

They have a strong concentration -dependent killing rate.

So we give a big dose to hit them hard.

Right.

And they have a long post -antibiotic effect.

So even when the drug leaves the body, the bacteria stays suppressed until the next dose.

So we know about MIC and killing rates.

But how do we actually find out if a specific bug is sensitive to a specific drug?

The text has a whole box, box 37 .1, on this lab work.

This is the detective work.

We can't just guess.

We have three main ways to test this in the lab.

First is the broth dilution test.

Is this just tubes of soup?

Essentially.

You have a row of tubes with nutrient broth.

You put the same amount of bacteria in each.

But you put decreasing amounts of antibiotic in them.

You incubate them overnight.

And then you look.

And you're looking for cloudiness.

Bacteria make the broth cloudy.

If the drug is working, the broth stays clear.

The first tube that is clear, meaning no growth, that concentration, is your MIC.

Simple.

What's the next method?

The disc diffusion method, or the Kirby Bauer test.

This one is more visual.

You take an agar plate, a petri dish, and smear bacteria all over it so it creates a lawn of growth.

Then you drop little paper disks impregnated with different antibiotics onto the surface.

And you wait to see what happens.

As the drug diffuses out of the paper disk into the jelly,

it kills the bacteria around it.

You get these clear circles called zones of inhibition.

Like crop circles of death.

Exactly.

You measure the diameter of the circle.

A big circle means the drug spread far and still killed the bugs.

So the bacteria are very sensitive.

A small circle, or no circle, means they are resistant.

And the third method, the E -test.

This combines the two.

It's a plastic strip that has a gradient of antibiotic on it.

High concentration at the top, low at the bottom.

You place it on the plate.

The text describes the result as a tear -shaped zone.

It does.

The bacteria grow closer to the strip where the concentration is low, and stay far away where it's high.

Where the bottom of that teardrop shape touches the strip, that number printed on the strip is your exact MIC.

That seems like the best of both worlds.

Precise numbers, but easy to read.

It is reliable and convenient.

But remember, knowing the MIC is just step one.

The text emphasizes that for a drug to be effective in a patient,

the peak serum concentration usually needs to be 4 to 10 times higher than the MIC.

Because getting the drug into the blood and then to the tissue is a whole other challenge.

Just because it works in a petri dish doesn't mean it works in a lung.

Exactly.

Now, we arrive at arguably the most critical part of this chapter.

The conflict.

The war.

Microbial resistance.

This is the arms race.

We develop a weapon, they develop a shield.

We build a better weapon, they change the lock.

And honestly, this is the part of the chapter that keeps infectious disease doctors awake at night.

The text distinguishes between innate and acquired resistance.

Innate seems simple enough.

Innate is structural.

Some bacteria just naturally don't have the target.

If you use a drug that attacks a cell wall,

but the organism doesn't have a cell wall.

It's not going to work, like trying to pop a balloon that isn't there.

Right.

Or if you use penicillin G on a gram -negative bacterium, the drug simply cannot penetrate the outer membrane to get to the wall.

It's innate.

But acquired resistance is the real threat.

This is where a previously sensitive bug becomes resistant.

How does that happen?

Two main ways.

First, mutation.

The text says spontaneous mutations occur at a rate of about 1 in 10 to the power of 12.

That sounds incredibly rare.

1 in a trillion.

It sounds rare, but think about how fast bacteria replicates and how many are in an infection.

A single abscess can contain billions of bacteria.

So the lottery is happening constantly.

And here is the danger.

Selection.

This is where we mess up, right?

If you expose the bacteria to a suboptimal dose of antibiotic, maybe the patient stops taking the pills too early because they feel better, or the dose is too low, you kill off the weak, sensitive bacteria.

But you leave that one mutant survivor.

And now that mutant has no competition, it has all the food and space to itself.

Exactly.

It replicates.

And suddenly the entire infection is resistant.

You have bred a superbug.

That's terrifying.

But the text mentions something even scarier.

The internet of bacteria.

Transferable resistance.

This is bacterial conjugation.

This is where it gets sci -fi.

Explain this to me.

Imagine if I learned how to do karate.

That's great for me.

But I can't just touch your arm and instantly transfer my karate knowledge to your brain.

Right.

I have to teach you.

It takes years.

Okay.

But bacteria can do the instant download.

Through a process called conjugation, they build a physical bridge between two cells.

A sexpillus.

And they photocopy a piece of DNA called a plasmid or R factor.

This plasmid contains the cheat codes for beating the antibiotic.

They slide it across the bridge and boom.

Now the second bacteria knows karate.

And the text implies this isn't just family to family.

No, that's the truly terrifying part.

An E.

coli can pass this data to a salmonella.

It's like a human teaching a dog how to do karate.

It crosses species barriers.

So that's how it spread so fast.

This is how we get these multi -drug resistant organisms spreading so fast in hospitals.

You have harmless gut bacteria acquiring resistance and then passing it off to a legal pathogen.

So what are they actually sharing?

What are the mechanisms of resistance?

Table 37 .1 breaks this down into three categories.

I labeled them the destroyer, the bouncer, and the disguise.

I love that.

Let's start with the destroyer.

This is drug inactivation.

Right.

The bacteria produce an enzyme that literally seeks out and destroys the drug.

The classic example is beta -lactamase.

That's the enzyme that breaks penicillin.

Yes.

Penicillin has a chemical structure called a beta -lactam ring.

It's a square ring.

That ring is the tension, the spring, that makes the drug work.

Okay.

The bacteria produce beta -lactamase, which acts like a pair of fizzers.

Snip.

The ring pops open.

The drug is now useless.

It's like cutting the fuse on a bomb.

What about the bouncer?

This is decreased accumulation.

The bacteria either stop the drug from getting in or they throw it out.

Throw it out?

It's called efflux.

The bacteria have transport proteins in their membrane -like p -glycoprotein that act as bouncers.

As soon as the antibiotic molecule slips inside the cell,

this pump grabs it and physically throws it back out into the environment.

You're not on the list.

Get out.

It's extremely effective.

The drug enters, gets booted, enters, gets booted.

It can never build up a high enough concentration inside the cell to do damage.

And which drugs does this work against?

The text mentions this is a primary way bugs resist tetracyclines and fluoroquinolones.

And finally, the disguise.

Reduced affinity.

This is changing the lock.

How does that work?

Remember, drugs work by binding to a specific target like a receptor or an enzyme inside the bacteria, like a key fitting a lock.

Right.

If the bacteria mutate that target, just slightly change its shape by a few atoms,

the drug can no longer bind.

The key doesn't turn.

Precisely.

This happens with sulfonamides, ribosomal inhibitors, DNH irase.

Almost all classes face this.

The drug is floating there, intact, but it has nowhere to attach.

So the bacteria are destroying our drugs with enzymes, pumping them out with bouncers and changing their locks so the keys don't fit.

It's a full -on defense system.

It really emphasizes why we need to be smart about how we use these things, which leads us to selection of drugs.

The clinical decision matrix.

It's not enough to know drug A kills bug B.

You have to look at the patient.

The text calls these host factors.

Let's run through the scenarios.

Pregnancies.

Big concern.

Most drugs cross the placenta.

The text warns specifically about tetracyclines.

They stain the baby's teeth.

Permanently.

Tetracycline binds to calcium.

If a fetus is developing teeths or bones, the drug gets incorporated into the structure.

The child will have brown, discolored teeth for life.

So you avoid them.

Absolutely.

But penicillins and cephalosporins are generally safe.

Then there are allergies.

Penicillins are the most common cause of drug allergy.

From a mild rash to anaphylactic shock.

You have to ask the history.

What happened when you took it?

And we touched on this earlier.

Immune status.

Critical.

If the patient has HIV, diabetes, or is on cancer meds,

you need bactericidal drugs.

You need higher doses.

You can't rely on the static drugs to hold the line because there are no troops to back them up.

The text also mentions abscesses.

This was interesting.

It talks about poor blood flow.

An abscess is a collection of pus.

It's a terrible environment for antibiotics.

The pH is wrong.

The oxygen is low.

And most importantly, there's no blood flow to deliver the drug into the center of the pus pocket.

So what do you do?

Just give more drugs?

No.

It won't work.

You have to drain it surgically.

Yeah.

There was an old Latin saying in medicine.

Ubipus.

Ebivacua.

Where there is pus, let it out.

Antibiotics alone usually fail there.

And of course, renal and hepatic function.

The garbage disposal system.

The kidneys and liver clear these drugs from the body.

Right.

If a patient's kidneys are failing and you give them a standard dose of an amyloglycoside, which is cleared by the kidneys, it won't leave the body.

It will build up to toxic levels and damage the kidneys further or cause deafness.

So you have to adjust.

You have to lower the dose or extend the interval.

It's a balancing act.

You need enough drug to kill the bug, but not so much that you kill the kidneys.

Exactly.

Now, aside from the patient's status, we have to think about where the infection is.

Location, location, location.

Pharmacokinetic.

Can the drug get to the bug?

This is often the reason for treatment failure.

The CNS central nervous system seems like the hardest place to get into.

It is.

The blood -brain barrier is a formidable wall designed to keep toxins out of the brain.

Unfortunately, it also keeps drugs out.

Meningitis is an infection of the membranes covering the brain.

And the text notes that penicillin G can cross, but only when the meninges are inflamed.

Wait, inflammation helps.

Paradoxically, yes.

The inflammation makes the barrier a bit leaky.

So when the patient is sick, as the drug can get in, but as they get better and the inflammation subsides, the barrier closes up again and the drug levels in the brain drop.

That is tricky.

What about drugs that never cross, like aminoglycosides?

If you need an aminoglycoside for meningitis, you can't just put it in the IV.

You have to inject it intraphetically.

Directly into the spinal canal?

Directly into the fluid bathing the brain.

It's an invasive procedure, but sometimes necessary.

What about bone?

Bone is very hard to penetrate.

It has low blood flow compared to soft tissue.

Osteomyelitis, bone infection, requires weeks or months of treatment to get enough drug in there to cure it.

And the prostate?

Tricky.

It has a specific barrier and the fluid is acidic.

The text explains that weak bases like trimethoprim can get in because of the pH gradient, but weak acids like penicillin are repelled.

It's chemistry again,

like dissolves like - Always.

Ideally, we'd know exactly what bug we are fighting and exactly where it is, but in the real world, we often have to guess.

The text calls this empiric therapy.

This is the educated guess.

A patient comes in with a severe infection fever, low blood pressure.

You can't wait 48 hours for the lab to grow the bug and do the disc diffusion test.

They might be dead by then.

So what do you do?

You treat based on the most likely cause, given the symptoms and location.

If it's a urinary tract infection, you guess E.

coli.

If it's skin, you guess staph.

And you use a broad spectrum drug to cover your bases.

But you switch once the results are in.

Ideally, yes.

This is called de -escalation.

You start broad, empiric, and narrow down once you have the identification definitive.

You switch from the shotgun to the sniper rifle to spare the patient's microbiome and reduce resistance.

Now, sometimes one drug isn't enough.

We move on to combination drug therapy.

Is one plus one always two?

Rarely in pharmacology.

Figure 37 .6 outlines the possibilities.

You have indifference, where the combination does nothing special.

You have additive, where one plus one go two.

But then you have the holy grail, synergism.

Synergism, one plus one equals three.

The combined effect is greater than the sum of the parts.

Box 37 .2 gives a classic example.

Penicillin plus an aminoglycoside.

Explain how they work together.

This is a beautiful cooperation.

Remember, aminoglycosides work inside the cell on the ribosome.

But they have trouble getting through the cell wall.

Penicillin breaks the wall.

It punches holes in the armor.

So penicillin opens the door.

And the aminoglycoside walks right in and shuts down the factory.

They help each other.

Another one was sulfamethoxazole plus trimethoprim.

They block sequential steps in the same pathway.

Both drugs block the production of folic acid.

It's like setting up a police roadblock at mile one and another at mile 10.

If the bacteria manages to sneak past the first one, the second one catches them.

Nothing gets through.

But there's a dark side.

Antagonism.

This is dangerous.

One plus one is less than one.

The combination is worse than either drug alone.

How is that possible?

The classic mistake is combining a bacteriostatic drug with a bactericidal drug.

Why is that bad?

Think back to penicillin.

It kills bacteria that are actively building cell walls.

Yeah.

Which means they must be growing and divining.

Right.

Now imagine you add tetracycline.

Tetracycline is bacteriostatic.

It stops growth.

It freezes the bacteria.

So the bacteria aren't growing.

The penicillin has nothing to attack.

You have effectively neutralized your killer drug by pausing the target.

You turned off the enemy just when your sniper was about to take the shot.

Fascinating.

So you have to know your mechanisms.

Now, besides synergy, why else do we combine drugs?

To prevent resistance.

The text uses tuberculosis,

TB, as the prime example.

I love the math here.

It's simple probability.

Let's say the chance of a TB bacterium mutating to resist drug A is one in a million.

10 to the minus six.

OK.

And the chance for it to mutate against drug B is also one in a million.

So if I give both drugs at the same time?

The chance of a single bacterium mutating to resist both drugs simultaneously is those probabilities multiplied.

10 -6 times 10 -6 is 10 -12.

One in a trillion.

And since a patient usually has fewer than a trillion bacteria in their body?

The odds of a double resistant mutant emerging are practically zero.

That is why we treat TB with four drugs at once.

We are playing the odds game to ensure no survivors.

Finally, we have prophylactic therapy.

This is using drugs to prevent infection before it happens.

It's controversial because overuse drives resistance.

But there are specific indications where the benefits outweigh the risks.

Surgical prophylaxis makes sense.

You give a single dose right before the surgeon cuts.

You want high levels of antibiotic in the blood at the moment the skin is broken to prevent skin bacteria like staph from infecting the incision.

But the text notes you shouldn't continue it for days afterwards.

Right.

Once the wound is closed, the risk is gone.

Continuing the drug just breeds resistance.

And endocarditis.

This is for people with damaged heart valves.

If they go to the dentist for cleaning, the scraping causes bleeding.

Bacteria from the mouth can get into the blood, bacteremia, and settle on the damaged heart valve.

Okay.

So they take antibiotics an hour before the dentist to clear the blood.

And lastly,

disease transmission.

Like taking anti -malarials when traveling to the tropics or giving rifampin to someone who's in the same room as a person with meningitis, you are trying to break the chain of transmission.

While we have unpacked the entire chapter, we've gone from moldy being curd to the intricate math of resistance probabilities.

It's a massive field.

But the principles are surprisingly logical once you break them down.

So if we look at the big picture, what does this all mean for us?

It goes back to that arms race.

The text mentions it repeatedly.

We are in a constant battle.

We find a mechanism, selective toxicity, and the bacteria find a way around it.

It feels like we are running on a treadmill.

We invent a new drug.

They invent a new pump.

We are.

And that's the provocative thought I want to leave everyone with.

The text emphasizes that our best defense isn't just stronger drugs.

It's understanding the mechanism.

If we know how resistance happens, if we know about the efflux pumps and the beta -lactamases, we can design smarter strategies.

We can build inhibitors for the pumps.

We can build decoys for the enzymes.

Intelligence over brute force.

Exactly.

Because in a brute force war against bacteria, they have the numbers.

They replicate every 20 minutes.

They will always win a numbers game.

We have to outsmart them.

A sobering but inspiring thought to end on.

We have to stay one step ahead in the chess game.

Thank you so much for walking us through this.

My pleasure.

And thank you to you, the listener, for diving deep with us.

A big shout out to the Last Minute Lecture team for helping put this together.

Until next time, keep learning.